Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).
Kamps WA, Bökkerink JP, Hählen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, van den Berg-de Ruiter E, Smets LA, de Vaan GA, Weening RS, van Weerden JF, van Wering ER, den der Does-van den Berg A. Kamps WA, et al. Blood. 1999 Aug 15;94(4):1226-36. Blood. 1999. PMID: 10438710 Free article. Clinical Trial.
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Ramakers-van Woerden NL, Pieters R, Hoelzer D, Slater RM, den Boer ML, Loonen AH, Harbott J, Janka-Schaub GE, Ludwig WD, Ossenkoppele GJ, van Wering ER, Veerman AJ; Dutch and German Leukemia Study Groups. Ramakers-van Woerden NL, et al. Among authors: slater rm. Med Pediatr Oncol. 2002 Jun;38(6):379-86. doi: 10.1002/mpo.10087. Med Pediatr Oncol. 2002. PMID: 11984797
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
Ramakers-van Woerden NL, Pieters R, Slater RM, Loonen AH, Beverloo HB, van Drunen E, Heyman M, Moreno TC, Rots MG, van Wering ER, Kamps WA, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: slater rm. Br J Haematol. 2001 Mar;112(3):680-90. doi: 10.1046/j.1365-2141.2001.02586.x. Br J Haematol. 2001. PMID: 11260073 Free article.
Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study Group.
Slater RM, Smeets DF, Hagemeijer A, De Jong B, Beverstock CG, Geraedts JP, van der Does-van den Berg A, van Wering ER, Veerman AJ. Slater RM, et al. Haematol Blood Transfus. 1990;33:169-73. doi: 10.1007/978-3-642-74643-7_33. Haematol Blood Transfus. 1990. PMID: 2138993 Clinical Trial. No abstract available.
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
Hasle H, Aricò M, Basso G, Biondi A, Cantù Rajnoldi A, Creutzig U, Fenu S, Fonatsch C, Haas OA, Harbott J, Kardos G, Kerndrup G, Mann G, Niemeyer CM, Ptoszkova H, Ritter J, Slater R, Starý J, Stollmann-Gibbels B, Testi AM, van Wering ER, Zimmermann M. Hasle H, et al. Leukemia. 1999 Mar;13(3):376-85. doi: 10.1038/sj.leu.2401342. Leukemia. 1999. PMID: 10086728
134 results